Ligand Pharmaceuticals (LGND) Inventory Average (2011 - 2026)
Ligand Pharmaceuticals (LGND) posted Inventory Average of $11.2 million for Q1 2026, up 6.5% sequentially from $10.5 million in Q4 2025, and down 22.06% YoY from $14.4 million in Q1 2025.
Ligand Pharmaceuticals (LGND) Inventory Average (2011 - 2026) Analysis & Trends
Ligand Pharmaceuticals has reported Inventory Average for 16 years, with the latest figure at $11.2 million in Q1 2026.
- Quarterly Inventory Average fell 22.06% year-over-year to $11.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.2 million (down 22.06% YoY) and the FY2025 annual result came in at $11.6 million, down 38.98% from the prior year.
- Inventory Average advanced to $11.2 million in Q1 2026 per LGND's latest filing, from $10.5 million in the prior quarter.
- Over five years, Inventory Average peaked at $26.5 million in Q1 2022 and troughed at $10.5 million in Q4 2025.
- A 5-year average of $18.7 million and a median of $17.8 million in 2022 frame the typical range for Inventory Average.
- The sharpest annual moves came in 2023 and 2024: Inventory Average plunged 48.42% in 2023, then surged 65.93% in 2024.
- Over 5 years, Inventory Average stood at $17.8 million in 2022, then soared by 38.58% to $24.7 million in 2023, then sank by 37.49% to $15.4 million in 2024, then tumbled by 31.85% to $10.5 million in 2025, then grew by 6.5% to $11.2 million in 2026.
- According to Business Quant data, Inventory Average over the past three periods registered $11.2 million, $10.5 million, and $13.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 707.10 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 355,998.06 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 90.57 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 137.65 Mn |
| 10 | Ligand Pharmaceuticals | 5.87 Bn | 4.51 Bn | 60.48 Mn | 11.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.76 Mn |
| Mar 31, 2026 | 11.20 Mn |
| Dec 31, 2025 | 10.51 Mn |
| Sep 30, 2025 | 13.69 Mn |
| Jun 30, 2025 | 15.05 Mn |
| Mar 31, 2025 | 14.36 Mn |
| Dec 31, 2024 | 15.43 Mn |
| Sep 30, 2024 | 17.71 Mn |
| Jun 30, 2024 | 20.00 Mn |
| Mar 31, 2024 | 22.65 Mn |
| Dec 31, 2023 | 24.68 Mn |
| Sep 30, 2023 | 26.15 Mn |
| Jun 30, 2023 | 20.46 Mn |
| Mar 31, 2023 | 13.65 Mn |
| Dec 31, 2022 | 17.81 Mn |
| Sep 30, 2022 | 23.55 Mn |
| Jun 30, 2022 | 25.19 Mn |
| Mar 31, 2022 | 26.47 Mn |
| Dec 31, 2021 | 30.16 Mn |
| Sep 30, 2021 | 36.47 Mn |